Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2002 | 2010 | ||||||||
|
elastase, neutrophil expressed | 0.447 | 0.846 | 1.2E-03 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2004 | 2008 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2008 | 2012 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2011 | 2014 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2006 | 2016 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2010 | 2012 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2010 | 2018 | ||||||||
|
histone deacetylase 1 | 0.460 | 0.846 | 0.61 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2006 | 2014 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2005 | 2008 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 1998 | 2008 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2010 | 2014 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2007 | 2012 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2004 | 2011 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
phenotype | 0.200 | None | 1.000 | 3 | 0 | 2003 | 2012 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 1996 | 2014 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2002 | 2011 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2012 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 1992 | 2009 | ||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2008 | 2011 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2001 | 2010 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
neuropeptide Y receptor Y1 | 0.628 | 0.423 | 4.3E-02 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2007 | 2012 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2000 | 2015 |